Literature DB >> 10932160

Pulsed electric fields for selection of hematopoietic cells and depletion of tumor cell contaminants.

H M Eppich1, R Foxall, K Gaynor, D Dombkowski, N Miura, T Cheng, S Silva-Arrieta, R H Evans, J A Mangano, F I Preffer, D T Scadden.   

Abstract

Purging of tumor cells and selection of stem cells are key technologies for enabling stem cell transplantation and stem cell gene therapy. Here we report a strategy for cell selection based on physical properties of the cells. Exposing cells to an external pulsed electric field (PEF) increases the natural potential difference across the cell membrane until a critical threshold is reached and pore formation occurs, resulting in fatal perturbation of cell physiology. Attaining this threshold is a function of the applied field intensity and cell size, with larger cells porated at lower field intensities than smaller cells. Since hematopoietic stem cells are smaller than other hematopoietic cells and tumor cells, we found that exposure of peripheral blood mononuclear cells (PBMCs) to PEFs caused stepwise elimination of monocytes without affecting the function of smaller lymphocyte populations. Mobilized peripheral blood exposed to PEFs was enriched for CD34+/CD38- cells and stem cell function was preserved. Furthermore, PEF treatment was able to selectively purge blood preparations of tumor cells and eradicate transplantable tumor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10932160     DOI: 10.1038/78504

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  8 in total

Review 1.  Blood-on-a-chip.

Authors:  Mehmet Toner; Daniel Irimia
Journal:  Annu Rev Biomed Eng       Date:  2005       Impact factor: 9.590

2.  Microfluidic electroporation of tumor and blood cells: observation of nucleus expansion and implications on selective analysis and purging of circulating tumor cells.

Authors:  Ning Bao; Thuc T Le; Ji-Xin Cheng; Chang Lu
Journal:  Integr Biol (Camb)       Date:  2010-01-05       Impact factor: 2.192

3.  Enhancing Irreversible Electroporation by Manipulating Cellular Biophysics with a Molecular Adjuvant.

Authors:  Jill W Ivey; Eduardo L Latouche; Megan L Richards; Glenn J Lesser; Waldemar Debinski; Rafael V Davalos; Scott S Verbridge
Journal:  Biophys J       Date:  2017-07-25       Impact factor: 4.033

Review 4.  Microfluidic electroporation for cellular analysis and delivery.

Authors:  Tao Geng; Chang Lu
Journal:  Lab Chip       Date:  2013-10-07       Impact factor: 6.799

5.  A novel potent Fas agonist for selective depletion of tumor cells in hematopoietic transplants.

Authors:  A Nahimana; D Aubry; L Lagopoulos; P Greaney; A Attinger; S Demotz; K M Dawson; M Schapira; J Tschopp; M Dupuis; M A Duchosal
Journal:  Blood Cancer J       Date:  2011-12-09       Impact factor: 11.037

6.  Decreasing the thresholds for electroporation by sensitizing cells with local cationic anesthetics and substances that decrease the surface negative electric charge.

Authors:  Maciej Grys; Zbigniew Madeja; Włodzimierz Korohoda
Journal:  Cell Mol Biol Lett       Date:  2014-01-10       Impact factor: 5.787

7.  Reversible and irreversible electroporation of cell suspensions flowing through a localized DC electric field.

Authors:  Włodzimierz Korohoda; Maciej Grys; Zbigniew Madeja
Journal:  Cell Mol Biol Lett       Date:  2012-12-27       Impact factor: 5.787

8.  Targeted cellular ablation based on the morphology of malignant cells.

Authors:  Jill W Ivey; Eduardo L Latouche; Michael B Sano; John H Rossmeisl; Rafael V Davalos; Scott S Verbridge
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.